Welcome to Sequella

Sequella is a clinical stage biopharmaceutical company focused on commercializing improved treatments for serious infectious diseases. The company leverages its global influence, R&D platforms and infectious disease expertise to proactively address emerging health threats.

Through focused execution, clear commercialization pathways, and strategic partnerships, Sequella intends to commercialize a broad product portfolio designed to treat infectious disease threats with significant market opportunity.